Elevate GLP1: What It Is and What UK Patients Should Know (October 2026)

01 · Decision

Is Elevate GLP1 relevant to you in the UK?

Probably not.

The practical issue for UK readers is regulation. A UK supplier of prescription-only medicines should be registered with the General Pharmaceutical Council, and you can look the pharmacy up yourself on the GPhC register. Ours is GPhC 9012878.

02 · Next step

What to check before using any GLP-1 service

• Is the pharmacy on the GPhC register, and does it name a UK prescriber?
• Is the product a licensed medicine, such as Mounjaro or Wegovy, rather than a "compounded" or "dupe" version? See our guide to the Mounjaro dupe problem and to any Mounjaro biosimilar claims.
• Are you being asked to pay without a consultation or prescription? Walk away.
• Is the price shown the price paid, with no hidden fees?

If you are ready to compare licensed UK options, our weight loss clinic explains the process, and the Wegovy pen is the alternative to Mounjaro.

Related guides: Rowe glp1 and Pmos glp1.

03 · What tirzepatide is

What tirzepatide is

Mounjaro is the brand name for tirzepatide, a once-weekly injectable prescription medicine made by Eli Lilly. In the UK it is licensed for weight management in adults and for type 2 diabetes. It comes as a pre-filled multi-dose pen (KwikPen) in six strengths: 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg and 15mg.¹

Tirzepatide is the first treatment of its kind to activate two natural gut-hormone receptors at once: GIP and GLP-1. Together these help regulate appetite, slow how quickly the stomach empties, and improve the way the body responds to insulin.¹ Once in use, a pen can be kept out of the fridge at a temperature not above 30°C for up to 30 days after first use and must then be thrown away; unopened pens are stored in the fridge at 2–8°C.¹³

04 · What the evidence shows

What the evidence shows

The main trial for tirzepatide in obesity is SURMOUNT-1. In the SURMOUNT-1 trial of 2,539 adults, people taking tirzepatide alongside diet and exercise lost on average 15% of their body weight on 5mg, 19.5% on 10mg and 20.9% on 15mg over 72 weeks, compared with 3.1% with lifestyle changes alone.²

These are trial averages — individual results vary, and treatment works alongside a reduced-calorie diet and increased physical activity, not instead of them.² Trial averages do not predict your own result.

05 · Downsides and stopping

Downsides, side effects and stopping

Like all medicines, Mounjaro can cause side effects, and most are digestive. The most common — affecting more than 1 in 10 people — are nausea, diarrhoea, vomiting, constipation and abdominal discomfort. Common effects (up to 1 in 10) include indigestion, reduced appetite, dizziness, reflux, burping, hair shedding and injection-site reactions. Tell your prescriber about any new or lasting symptom. You can also report suspected side effects through the Yellow Card scheme.¹⁹

Whether you must stay on treatment indefinitely is a decision for you and your prescriber. In SURMOUNT-4, people who stopped tirzepatide after 36 weeks regained on average 14% of body weight over the following year, while those who continued treatment lost a further 5.5% on average. Stopping should always be planned with your prescriber. After a final dose, tirzepatide takes roughly four to five weeks to clear the system, and nothing needs doing while it clears.¹

There is no natural way to "increase your GLP-1" that matches a licensed medicine. Low-cost supplements carry no clinical oversight and dosing is not standardised. Our piece on GLP-1 reviews and complaints covers what people commonly raise about providers.

06 · UK access and NHS

UK access: NHS and private

Mounjaro is available on the NHS, but access is being phased in over several years. NICE recommends it for adults with a BMI of at least 35 plus at least one weight-related condition, and the NHS primary-care rollout began in June 2025 with the highest-need groups first (initially BMI 40+ with four or more qualifying conditions).⁴ Full rollout is expected to take years, which is why many people who meet the licensed criteria choose regulated private treatment rather than waiting.⁶

Privately with us, a free consultation is reviewed by a GPhC-registered prescriber, with free next-day tracked delivery and ongoing monthly reviews. New customers save £40 on their first order with code FIRST40, and an automatic £25 reorder discount applies to every future order (code DOSE25). Mounjaro is a prescription-only medicine, used alongside a reduced-calorie diet and increased physical activity. Individual results vary.¹

07 · Serious side effects

Serious side effects: when to get help straight away

Serious side effects are uncommon but need urgent attention. Seek immediate medical help for: severe, persistent stomach pain that may spread to your back, with or without vomiting (possible pancreatitis); pain in the upper right abdomen, fever or yellowing of skin/eyes (possible gallbladder problems); or signs of a severe allergic reaction such as swelling of the face or throat and difficulty breathing. If you take insulin or a sulfonylurea alongside Mounjaro, watch for low blood sugar (shakiness, sweating, confusion) — your prescriber may need to adjust those medicines.¹